In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study

by Martin van Zyl, MB, ChB, Waldemar E. Wysokinski, MD, PhD, Thomas M. Jaeger, MD, Ana I. Casanegra, MD, Bernard J. Gersh, MB, ChB, DPhil, Robert D. McBane, II, MD
Published 2020-10-01

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation

by Waldemar E. Wysokinski, MD, PhD, Rowlens M. Melduni, MD, MPH, Naser M. Ammash, MD, Danielle T. Vlazny, PA-C, MS, Ewa Konik, MD, Rayya A. Saadiq, DO, Izabela Gosk-Bierska, MD, Joshua Slusser, BS, Diane Grill, MS, Robert D. McBane, MD
Published 2021-03-01

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism

by Julia C. Cambron, BS, Elias S. Saba, BS, Robert D. McBane, MD, Ana I. Casanegra, MD, Hector R. Villarraga, MD, Damon E. Houghton, MD, Danielle T. Vlazny, PA-C, MS, David Froehling, MD, David Hodge, MS, Lisa G. Peterson, MAN, RN, Dalene M. Bott-Kitslaar, APRN, CNP, Waldemar E. Wysokinski, MD, PhD
Published 2020-06-01